AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 21 min read$AXON

Kalinowski Caitlin Elizabeth sold $19K of AXON

Kalinowski Caitlin Elizabeth sold 40 shares of AXON ENTERPRISE, INC. (AXON) at $484.11 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

Insider sales can marginally influence short-term sentiment, but without accompanying guidance, contract, litigation, or operational updates, the trading edge is limited.

02

Market read

Primarily a sentiment/positioning datapoint; not a standalone fundamental catalyst.

03

What to watch

No 10b5-1 plan is stated, but the filing alone does not reveal whether the sale was tax-related, scheduled for personal reasons, or driven by diversification constraints.

Relevance 6/10Novelty 2/10Timing: After-hours/filing update on 2026-06-02 for the 2026-06-01 sale

Background

The article is an SEC Form 4 insider transaction filing for Axon Enterprise, reporting a director’s open-market sale.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon director Caitlin Elizabeth Kalinowski filed an open-market sale of 40 shares at $484.11 on 2026-06-01 (no 10b5-1 plan stated).

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/flow rather than a new catalyst.

Evidence & confidence

The filing provides a specific transaction size and price, but insider selling without a stated catalyst typically has limited predictive power versus earnings, guidance, or deal/regulatory news.

Market effects

Sector

None—single-company insider transaction with no sector-wide signal.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

The sale could be routine liquidity/portfolio rebalancing rather than a bearish signal, especially given the small number of shares relative to typical institutional flows.

Key entities

  • issuer
    AXON ENTERPRISE, INC.

    Company whose director insider sale is disclosed via SEC Form 4.

  • insider
    Kalinowski Caitlin Elizabeth

    Director who sold 40 shares at $484.11 on 2026-06-01; holdings after transaction: 3,632 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AXON insider trading history →

Related articles

AUG 23
$AXONMedAI 8/10

Axon’s AI Era Revenue Jumped Nearly 700%. Here’s What’s Behind It

Axon Enterprise (AXON) reported 35% revenue growth to $904M, beating estimates. AI Era revenue surged nearly 700% YoY. Management raised full-year guidance to 32-34% growth. Gross margin slipped 40 basis points to 62.9%. Analysts estimate a target price of $714, implying 13.7% upside over 2.4 years. The stock trades at 70x forward earnings, with growth driven by software and AI products.

tikr.com3 min
AUG 20
$BABAHighAI 8/10

Breakfast News: Alibaba's AI Push Comes at a Cost

Alibaba's Q1 revenue rose 9% to $39.6B, but operating income fell 57% due to tech investments. BILL Holdings reported 14% revenue growth and 80% operating income increase. U.S. debt surpassed $40T, with Treasury buybacks easing yield pressure. Apple plans 2027 launch for camera AirPods. Axon Enterprise passes competitive position tests, with a 69% potential upside to $1,088.08.

fool.com4 min
AUG 10
$AXONMed

Axon Stock Rebounds As Its Margin Squeeze Looks Like The Price Of Growth

Axon Enterprise (AXON) shares rose 9.3% on Friday after a 14.3% drop the prior session following its Q2 2026 results. The quarter showed revenue of $904 million, up 35% year over year, and a raised full-year outlook. The market disagreed over margin compression tied to higher memory costs and counter-drone hardware mix, with Axon expecting Q3 adjusted EBITDA margin to hold and rebuild in Q4.

finance.yahoo.com4 min
AUG 7
$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

aol.com4 min